Medical device and life science development group Sunrise Labs said this week that it completed its succession plan, with president Eric Soederberg acquiring the majority of shares in the company through a stock sale with founder and board chair Drew Sunstein. With the transaction, the Bedford, N.H.-based company said that it secured its planned ownership […]
IlluminOss Medical Inc.
IlluminOss Medical wins de novo nod from FDA for bone stabilization system
The FDA last month granted de novo clearance to the photodynamic bone stabilization system developed by IlluminOss Medical. The IlluminOss device uses a light-curable polymer, delivered in an expandable balloon catheter, to stabilize bone fractures. In a Dec. 19 letter to the East Providence, R.I.-based company, the FDA granted de novo clearance for an indication for […]
IlluminOss Medical pulls in $5m, looks for $20m more
IlluminOss Medical raised $5 million in a new round of equity financing and looks to raise another $20 million, according to an SEC filing posted today. The offering was made to cover the purchase of the company’s Series AA preferred stock and the exchange of shares of the company’s Series A, B and C1 preferred stocks […]
OmniGuide vet Avila gets picked as new IlluminOss CEO | Personnel Moves
IlluminOss Medical said today it picked ex-OmniGuide sales & marketing veep Manny Avila as its new chief exec. Prior to his time as sales & marketing veep with OmniGuide, Avila served as veep of commercial operations and surgical solutions in Europe for Covidien, and had management roles at Aspect Medical, Synthes Inc. and Haemonetics (NYSE:HAE), IlluminOss […]
HART CEO Green bows out | Personnel Moves
IlluminOss launches U.S. trial for bone fracture device
IlluminOss Medical is diving into a new clinical trial to test its photodynamic bone stabilization system as a treatment for osteoporotic and fragility fractures.
IlluminOss wins FDA nod for bone fracture device trial
IlluminOss Medical said the FDA granted "conditional" clearance for a clinical trial of its photodynamic bone stabilization system, ahead of its bid for de novo clearance from the watchdog agency.
Arrhythmia names new CEO | Personnel Moves
Medical device angel investments jump in 2012
The medical device industry isn’t being left behind when it comes to angel investing, according to data provided to MassDevice.com from the investment data firm CB Insights.
Angel- and seed-round financing (typically $1.5 million or less) jumped dramatically in 2012, accounting for about 27% of all investment in the medical device industry. That’s a 50% increase compared with 2011.
IlluminOSS Medical nabs $28 million for bone angioplasty
IlluminOSS Medical, an early-stage medical device company that’s developing a minimally invasive internal fixation system for hand, wrist, clavicle and arm fractures raised $28 million from a syndicate of investors.
What keeps you up at night? – 2011 MassDevice.com Big 100 Roundtable Panel Discussion
MassDevice asks the CEOs of Zoll Medical, Semprus Biosciences, IlluminOss Medical and Good Start Genetics what keeps them up at night at the 2011 MassDevice.com Big 100 Roundtable East.
